News
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (HCM) (“HUTCHMED”, the “Company” or “we”) (HKEX ...
— HUTCHMED’s fourth product, and its first approval in hematological malignancies — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 21, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback